What QuidelOrtho (QDEL) Said on Its Q3 Earnings Call

QuidelOrtho (QDEL) Q3 2026 Earnings Call Transcript

China sales slump and a restructuring plan reshape the outlook

What QuidelOrtho (QDEL) Said on Its Q3 Earnings Call

QuidelOrtho (NASDAQ:QDEL) reported third-quarter revenue of $619 million, down 12% year over year on a constant-currency basis, as China pricing changes and softer respiratory testing demand continued to weigh on results. The company said revenue rose 3% excluding China, respiratory testing and the

QuidelOrtho Reports Third Quarter 2026 Financial Results

/PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a leading global provider of diagnostic solutions, today announced...

QuidelOrtho Targets More Than $80 Million in 2027 Savings

The company narrowed its 2026 revenue range to $2.52 billion-$2.54 billion and expects $30 million-$35 million in one-time restructuring charges in the fourth quarter.

QuidelOrtho Reports Third Quarter 2026 Financial Results - PressReach

― Growth in Labs and Immunohematology Outside of China Highlights Underlying Business Strength ― ― New Cost Transformation and Enterprise Restructuring Program Expected to Deliver Over $80 Million in Annual Savings in 2027 ― ― Updated Full-Year 2026 Financial Guidance Narrowing Prior Ranges ― SAN DIEGO, Nov. 3, 2026 /PRNewswire/ — QuidelOrtho Corporation (Nasdaq: QDEL) … Continue reading "QuidelOrtho Reports Third Quarter 2026 Financial Results"